Holen Sie sich die Stockscreener-App
0.9663
2.38%
0.0225
Handel nachbörslich:
.97
0.0037
+0.38%
Werewolf Therapeutics Inc Aktie (HOWL) Neueste Nachrichten
Werewolf Therapeutics stock gains on merger scrutiny and trial progress - AD HOC NEWS
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Werewolf Therapeutics Completes Key Early Trial For WTX-124 In Hard-To-Treat Cancers - TipRanks
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the MergerHOWL, HZO, TYFG and FULC - Sahm
Werewolf (HOWL) Outlook: Moves 102.57% Up to $0.87 in the Latest Reading; Boundary Watch: $0.83 and $0.91 Define the Nearby Reference Levels at the CloseMoving Average Ribbon - vinanet.vn
Werewolf and Ambros Therapeutics announce merger - The Pharma Letter
Werewolf Therapeutics (NASDAQ:HOWL) Deal Changes Pipeline Focus - Kalkine Media
Werewolf Therapeutics Shares Surge Twofold After Ambros Merger, Investors Retain 6.8% Stake - TechStock²
Latham Watkins Advises on Oversubscribed Private Placement in Werewolf Ambros Merger Transaction - Latham & Watkins LLP
Werewolf Therapeutics, Inc. announced that it expects to receive $150 million in funding - marketscreener.com
Werewolf Therapeutics Strikes Reverse Merger With Ambros, Secures $150 Million for Rare Pain Drug - finance.biggo.com
Trending Stocks Today | Werewolf Therapeutics Shoots up 117.27% - Moomoo
Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News - Yahoo Finance
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Watertown biotech agrees to reverse merger with Vivek Ramaswamy-backed startup - The Business Journals
Gold Moves Higher; US Composite PMI Surges In August - Benzinga
Werewolf Therapeutics (HOWL) Stock Soars 127% on Ambros Merger and $150M Financing Deal - Blockonomi
Werewolf Therapeutics stock soars on Ambros merger deal and $150 million PIPE - Quiver Quantitative
Ambros Therapeutics to merge with Werewolf Therapeutics in all-stock deal - Dealroom
Why is Werewolf Therapeutics stock surging more than 100% today? - Investing.com
Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug - Fierce Biotech
Why Is Werewolf Therapeutics Stock Gaining Friday?Werewolf Therapeutics (NASDAQ:HOWL) - Benzinga
Israel Englander's HOWL Stock Soars on $500M DealWerewolf Therapeutics (NASDAQ:HOWL) - Benzinga
Werewolf Therapeutics to Merge and Rebrand as Ambros - TipRanks
Werewolf Therapeutics shares surge 120% after Ambros merger and $150 million financing - Yahoo Finance
HOWL Stock Whipsaws As One-Off Profit Meets Uncertain Future - StocksToTrade
Why Is Penny Stock Werewolf Therapeutics (HOWL) Up Today? - TipRanks
Werewolf (NASDAQ: HOWL) Ambros deal leaves holders with single-digit stake - Stock Titan
Werewolf Therapeutics to Merge With Ambros in Stock Deal; Raises $150 Million PIPE, Holders Locked Up - TradingView
Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 Million Private Placement - Investing News Network
Werewolf Therapeutics stock soars 120% on Ambros merger deal - Investing.com
HOWL Stock Jumps As One-Off Deal Reshapes Outlook - StocksToTrade
HOWL Stock Jumps As One-Time Deal Fuels Q2 Profit - timothysykes.com
Werewolf Therapeutics to merge with Ambros in $150m deal - Investing.com
Werewolf Therapeutics, Ambros Therapeutics Plan Merger With $150 Million Financing - citybiz
Werewolf Therapeutics to merge with Ambros in $150m deal By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Werewolf Therapeutics and Ambros Therapeutics Announce - GlobeNewswire
Top Premarket Gainers - marketscreener.com
Great couple of days trading this!! 🐺 📊 📚 - Moomoo
Werewolf Therapeutics announces USD 150 million oversubscribed private placement of shares, pre-funded warrants - Bitget
Werewolf Therapeutics Shares Surge 89.94% After Hours on EMD Serono DealWerewolf Therapeutics (NASDAQ - Benzinga
Werewolf Therapeutics Sells Pre-Clinical Platforms to EMD for $33 Million - Minichart
Trending Stocks Today | Werewolf Therapeutics Soars 90.16% Post-Market - Moomoo
Werewolf Therapeutics Monetizes Platforms, Refocuses on Lead Programs - TipRanks
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Werewolf TherapeuticsOn August 14, Sells Inducer And Indukine Platforms To Emd Serono - TradingView
Werewolf Therapeutics Sells Preclinical Platforms to EMD Serono for $28M; Secures License for WTX-124/330 - TradingView
Werewolf Therapeutics (HOWL) Stock Is Trending Overnight—Here's Why It Jumped 90% After Hours - Sahm
$Werewolf Therapeutics (HOWL.US)$ - Moomoo
Werewolf Therapeutics (HOWL) Q2 2026 Earnings: EPS Delivers 130.17% Surprise, Stock Moves HigherGuidance Update - vinanet.vn
Werewolf Therapeutics Inc (NASDAQ: HOWL) Share Price, HOWL Stock News, HOWL Share Price & Updates - Kalkine
Werewolf Therapeutics Company Profile & Introduction - moomoo.com
ACTU Stock Price and Chart — NASDAQ:ACTU - TradingView
Werewolf Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Price to sales forward of Werewolf Therapeutics, Inc. – NASDAQ:HOWL - TradingView
Price to book forward of Werewolf Therapeutics, Inc. – NASDAQ:HOWL - TradingView
CNSY Stock Price and Chart — NASDAQ:CNSY - TradingView
Werewolf Therapeutics, Inc. (HOWL) Q2 2026 Financial Results: Key Risks, Losses, and Strategic Outlook - Minichart
Werewolf Therapeutics (HOWL) Plunges 27.8% to $0.36 as Biotech Stock Tests Critical SupportStop Run - dars.gov.et
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates - GlobeNewswire
HOWL Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Werewolf Therapeutics (HOWL) Q1 2026 Earnings: Narrower-Than-Expected Loss Per ShareEBITDA Estimate Trend - dars.gov.et
Werewolf Therapeutics Inc (HOWL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Werewolf Therapeutics Inc (HOWL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
HOWL|Werewolf Therapeutics Inc|Price:0.944|Chg%:-0.054 - TradingKey
Werewolf Therapeutics (HOWL) Stock Forum and Discussion - Moomoo
HOWL|Werewolf Therapeutics Inc|Price:0.427|Chg%:+0.067 - TradingKey
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):